SFS
ASND icon

Sowell Financial Services’s Ascendis Pharma A/S ASND Stock Holding History

Sowell Financial Services’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-284
Closed -$32K – 2454
2020
Q1 		$32K Buy
+284
New +$36.9K ﹤0.01% 1207

Other funds holding ASND

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Sowell Financial Services's ASND Position: Q2 2020 in Review

Sowell Financial Services sold out of Ascendis Pharma A/S (ASND) in Q2 2020, closing a stake of 284 shares — an estimated $32K sold.

Sowell Financial Services first reported a position in ASND in Q1 2020 and held it in 1 quarter. The position peaked at $32K in Q1 2020. 154 funds tracked by Wall St. Rank hold ASND as of Q2 2020.

  • Sowell Financial Services reported no remaining Ascendis Pharma A/S position as of Q2 2020 after selling out during the quarter.
  • Sowell Financial Services sold 284 Ascendis Pharma A/S shares in Q2 2020, an estimated $32K.
  • Sowell Financial Services first reported a position in Ascendis Pharma A/S in Q1 2020 and held it in 1 quarter.
  • Sowell Financial Services's Ascendis Pharma A/S position peaked at $32K in Q1 2020.
  • 154 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2020.

Based on Sowell Financial Services's 13F filing for Q2 2020, filed 13 Aug 2020.